Year: 2025
Type: article
Abstract: In this continuing medical education session at the 2024 Fall Clinical Dermatology Conference, James Q Del Rosso, Adjunct Clinical Professor of Dermatology at Touro University Nevada, Henderson, USA, and Karan Lal, Director of Pediatric Dermatology at Affiliated Dermatology, Scottsdale, USA, reviewed recent additions to the therapeutic armamentarium for acne and considered how to integrate new topical therapies into clinical practice in order to optimize outcomes for patients. Notable recent additions to dermatologists’ acne toolkit include newer dual and triple combination therapies, as well as agents with novel mechanisms, such as the androgen-receptor inhibitor clascoterone. Given the wide variety of topical therapies now available, Lal emphasized the importance of joint decision-making and individualized acne management that meets patients’ needs, as well as targeting underlying disease pathophysiology.
Author: Helen Boreham
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: Sun Pharma
OpenAlex ID: W4407811599